Author:
Gore Martin E,Griffin Clare L,Hancock Barry,Patel Poulam M,Pyle Lynda,Aitchison Michael,James Nicholas,Oliver Roderick TD,Mardiak Jozef,Hussain Tahera,Sylvester Richard,Parmar Mahesh KB,Royston Patrick,Mulders Peter FA
Funder
National Cancer Institute (Bethesda, MD, USA) and the EORTC Charitable Trust
Reference30 articles.
1. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0;Ferlay,2004
2. Current treatment of renal cell carcinoma;De Mulder;Ann Oncol,2004
3. Harkins D, Krapcho M, Mariotto A, et al, eds. National Cancer Institute. SEER cancer statistics review, 1975–2002. http://seer.cancer.gov/csr/1975_2002/ (accessed Feb 15, 2007).
4. Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma;Kriegmair;Urology,1995
5. Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer;Pyrhönen;J Clin Oncol,1999
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献